Abstract:Studies from recent years have identified a diverse population of both bacteria and fungi in the human vagina and several community signatures have emerged that are associated with susceptibility to infectious disease. A healthy vaginal bacterial microbiome is most frequently dominated by Lactobacillus species [1], yet a combination of other genera are isolated in vaginal swabs in both healthy and diseased states. The vaginal fungal mycobiome is dominated by Ascomycota, of which Candida species are the most abundant. Approximately 20% to 30% of healthy human vaginal samples contain detectable Candida at a single time point, with nearly all of those being C . albicans , and 70% of the population is expected to be vaginally colonized with Candida longitudinally [2]. Despite its prevalence in the healthy vaginal mycobiome, C . albicans is the most common causative agent of vulvovaginal candidiasis (VVC), a cause of significant morbidity in the human population. The next most common species implicated in VVC is C . glabrata , while other species including C . lusitaniae , C . tropicalis , C . parapsilosis , and C . krusei are also known to contribute to vaginal infections [3–5]. Non- albicans Candida species are typically more resistant to antifungal drugs than C . albicans [6], complicating therapeutic options and increasing treatment timelines. A disease state is often distinguished by an exaggerated inflammatory response at the vaginal mucosa [3] that leads to vulvar pruritis and erythema [7]. Polymorphic Candida species can initiate the process of filamentation, morphogenesis from single-celled yeast to multicellular hyphae, which is typically accompanied by increased tissue damage and inflammation [8]. Microbial dysbiosis has long been associated with VVC due to the observation that antibiotic usage dramatically increases the risk of onset. This notion has been challenged by several population studies [9,10]; however, other studies have found a close association between Candida and specific bacteria as well as distinct Lactobacillus species that were associated with decreased observation of fungi in samples or symptomatic VVC [11–15]. Taken together, the evidence suggests that specific bacterial species can have complex impacts on fungal burden and symptomatic infection. Shifts in the vaginal microbiome are also associated with other genital tract infections [13,16] including bacterial vaginosis (BV) and aerobic vaginitis (AV), which are characterized by the displacement of Lactobacillus species by other bacteria such as Gardnerella vaginalis , Streptococcus agalactiae , Staphylococcus aureus , Escherichia coli , and Enterococcus faecalis [17]. Both BV and AV are polymicrobial in nature and are associated with concurrent Candida carriage in many cases [18,19]. Mixed vaginitis, which can include BV or AV together with VVC, is particularly difficult to treat, and during late stages of pregnancy can lead to severe adverse maternal and neonatal outcomes [17,20]. Because it is the most abundant fungal genus in the vagina, this review will focus on the interactions between Candida species and the healthy and pathogenic bacteria found in the vaginal environment. These interactions play a significant role in maintaining homeostasis as well as impacting disease pathogenesis in the genital tract (Fig 1).

Diverse Vaginal Microbiomes in Reproductive-Age Women with Vulvovaginal Candidiasis.

Molecular Analysis of the Diversity of Vaginal Microbiota Associated with Bacterial Vaginosis

Diversity of Cervicovaginal Microbiota Associated with Female Lower Genital Tract Infections

Analysis of the structure of vaginal microbiota in vulvovaginal candidiasis

[Longitudinal Analysis of Vaginal Microbiota in Women with Recurrent Vulvovaginal Candidiasis].

Illumina Sequencing 16S Rrna Tagging Reveals Diverse Vaginal Microbiomes Associated with Bacterial Vaginosis

Comparative study of vaginal microflora of VVC and RVVC patients before and after treatment

Species composition and dynamic changes of vaginal microbiota in patients with recurrent vulvovaginal candidiasis

Associations Between Bacterial Vaginosis, Candida Vaginitis, Trichomonas Vaginalis, And Vaginal Pathogenic Community In Chinese Women

Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis

Mycobiome Study Reveals Different Pathogens of Vulvovaginal Candidiasis Shape Characteristic Vaginal Bacteriome

Clinical Significance of Composition and Functional Diversity of the Vaginal Microbiome in Recurrent Vaginitis

Interpretation of vaginal metagenomic characteristics in different types of vaginitis

Diversity of Lactobacillus in Vagina of Vulvovaginal Candidiasis

Large-scale Analysis of the Genetic and Epigenetic Alterations in Hepatocellular Carcinoma from Southeast China.

Highlight signatures of vaginal microbiota and metabolome contributed to the occurrence and recurrence of vulvovaginal candidiasis

Analysis of the Vaginal Microecology in Patients with Severe Vulvovaginal Candidiasis

Impact of interkingdom microbial interactions in the vaginal tract

The Restoration of the Vaginal Microbiota after Treatment for Bacterial Vaginosis with Metronidazole or Probiotics

Associations Between Vaginal Pathogenic Community And Bacterial Vaginosis In Chinese Reproductive-Age Women

Biased Genotype Distributions of Candida Albicans Strains Associated with Vulvovaginal Candidosis and Candidal Balanoposthitis in China.